---
figid: PMC3720830__nihms466800f7
figlink: /pmc/articles/PMC3720830/figure/F7/
number: F7
caption: 'CYP1A1 knock down by siRNA results in the dual inactivation ERK and AKT
  (1). Inactivation of ERK could presumably remove the suppressive pressure that this
  exerts on LKB1 (2), thereby allowing activation of AMPK (3). LKB1-independent mechanisms
  may also be possible. Additionally, inhibition of AKT could result in the release
  of its suppressive effect on AMPK (4). Alternatively, inhibition of AKT by CYP1A1siRNA
  could result in the release of the TSC1/2 complex from suppression (5), followed
  by release of RHEB (6), and subsequent inhibition of mTOR signaling (7). Alternatively,
  AMPK could directly activate TSC2 (5) and inhibit RAPTOR (7), thereby inhibiting
  mTOR signaling(8). In this manner CYP1A1siRNA treatment results in cell cycle arrest
  and increased apoptosis (9). In summary, we propose that CYP1A1siRNA-mediated inhibition
  of ERK1/2 and/or AKT results in AMPK activation, thereby inhibiting the mTOR/P70S6K
  pathway and thus resulting in cellular death. Legend: AMPK, AMP-activated protein
  kinase; ERK1/2, Extracellular Signal-Regulated Kinases 1 and 2; KSR, Kinase Suppressor
  of Ras; LKB1, Liver kinase B1; P70S6K, 70kDa ribosomal protein S6 kinase; RHEB,
  Ras homolog enriched in brain; TSC1/2, Tuberous sclerosis protein 1/2.'
pmcid: PMC3720830
papertitle: Cytochrome P450 1A1 Regulates Breast Cancer Cell Proliferation and Survival.
reftext: Mariangellys Rodriguez, et al. Mol Cancer Res. ;11(7):780-792.
pmc_ranked_result_index: '40962'
pathway_score: 0.9151286
filename: nihms466800f7.jpg
figtitle: Cytochrome P450 1A1 Regulates Breast Cancer Cell Proliferation and Survival
year: ''
organisms:
- Homo sapiens
ndex: aefed084-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3720830__nihms466800f7.html
  '@type': Dataset
  description: 'CYP1A1 knock down by siRNA results in the dual inactivation ERK and
    AKT (1). Inactivation of ERK could presumably remove the suppressive pressure
    that this exerts on LKB1 (2), thereby allowing activation of AMPK (3). LKB1-independent
    mechanisms may also be possible. Additionally, inhibition of AKT could result
    in the release of its suppressive effect on AMPK (4). Alternatively, inhibition
    of AKT by CYP1A1siRNA could result in the release of the TSC1/2 complex from suppression
    (5), followed by release of RHEB (6), and subsequent inhibition of mTOR signaling
    (7). Alternatively, AMPK could directly activate TSC2 (5) and inhibit RAPTOR (7),
    thereby inhibiting mTOR signaling(8). In this manner CYP1A1siRNA treatment results
    in cell cycle arrest and increased apoptosis (9). In summary, we propose that
    CYP1A1siRNA-mediated inhibition of ERK1/2 and/or AKT results in AMPK activation,
    thereby inhibiting the mTOR/P70S6K pathway and thus resulting in cellular death.
    Legend: AMPK, AMP-activated protein kinase; ERK1/2, Extracellular Signal-Regulated
    Kinases 1 and 2; KSR, Kinase Suppressor of Ras; LKB1, Liver kinase B1; P70S6K,
    70kDa ribosomal protein S6 kinase; RHEB, Ras homolog enriched in brain; TSC1/2,
    Tuberous sclerosis protein 1/2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND2
  - PRKAA1
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PRKAB2
  - MTOR
  - RPS6KB1
  - MAPK1
  - CCND1
  - MAP2K2
  - TSC1
  - KSR2
  - PRKAB1
  - RPS6KB2
  - CCND3
  - BIRC5
  - PRKAA2
  - MAP2K1
  - TSC2
  - RHEB
  - AKT1S1
  - MAPK3
  - AKT2
  - KSR1
  - RAF1
  - STK11
  - AKT3
  - ARAF
  - AKT1
  - BRAF
  - RPTOR
  - Cancer
  - Cardiomyopathy
genes:
- word: CyclinD,
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CyclinD,
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: KSR
  symbol: KSR
  source: bioentities_symbol
  hgnc_symbol: KSR2
  entrez: '283455'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: CyclinD,
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: KSR
  symbol: KSR
  source: bioentities_symbol
  hgnc_symbol: KSR1
  entrez: '8844'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAPTOR
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
figid_alias: PMC3720830__F7
redirect_from: /figures/PMC3720830__F7
figtype: Figure
---
